Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION-HF: Oral ferric maltol for iron deficiency and anaemia in heart failure
2021-000130-33Phase 4Completed
- Sponsor
- Hannover Medical School
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ferric maltol in heart failure (HF) and iron deficiency anemia (IDA), sponsored by Hannover Medical School. Started Sep 2022; status: completed.
02
Drugs
ferric maltol
03
Conditions
heart failure (HF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2021-000130-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000130-33.